CLINICAL_TRIALS
trial_result
· 2025-12-03
Clinical Trial Update: A Study to Assess the Safety of TPM502 in Adults With Celiac Disease [Phase 2]
Summary
Phase 2 safety study of TPM502 in adults with celiac disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Topas Therapeutics GmbH | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED